RecruitingNCT02139020
Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck Patients
Prospective Collection of Plasma Samples From Patients Treated With Molecular Targeted Therapies for Squamous Cell Carcinoma of the Head and Neck
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Enrollment
400 participants
Start Date
Feb 1, 2013
Study Type
OBSERVATIONAL
Conditions
Summary
The investigators will collect plasma samples at baseline, during treatment, and at progression.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- patients treated with radiation therapy and cetuximab according to Bonner et al
- patients treated with cetuximab in combination with chemotherapy according to Vermorken et al.
- patients treated with a molecular targeted agent as a part of a clinical study
Exclusion Criteria2
- patients with another type of head and neck cancer
- patients non treated with targeted therapies
Interventions
OTHERPlasma samples
Plasma samples at baseline (and one whole blood sample) and at every radiological evaluations
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02139020
Related Trials
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
NCT0520876261 locations
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
NCT062235681 location
Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
NCT067363791 location
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
NCT0578362218 locations
Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer
NCT0532953216 locations